If you use hemp CBD because your state doesn’t have a medical cannabis program or because prescriptions are too expensive, you could lose access in November with no alternative in place. Americans for Safe Access warns that patients who turned to hemp-derived CBD due to cost, access deserts, and limited state medical programs may face sudden loss of access when the Nov ban hits. The FDA’s cannabinoid deadline doesn’t establish clinical pathways, insurance coverage, or patient safeguards.